Sensorion Investor Relations Material

Sensorion SA is a clinical-stage biotechnology company focused on developing therapeutic solutions for inner ear disorders, particularly targeting hearing loss and balance disorders. The company's research and development efforts span from molecular biology to clinical research, aiming to address unmet medical needs related to inner ear pathologies. Sensorion's work includes developing drug treatments designed to restore, treat, and prevent these conditions, leveraging its expertise in animal pharmacology, toxicology, and clinical studies. The company is headquartered in Montpellier, France, and its shares are listed on the Euronext Paris.